Zydus Wellness financials

Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹1,437cr+66.9% on Q1 FY26
Net profit
₹119cr−7.0% on Q1 FY26
EBITDA margin
16.8%−1.2 pts on Q1 FY26
EPS
₹3.74−81.4% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue1,437861+66.9%
EBITDA242156+55.3%
EBITDA margin16.8%18.1%−1.2 pts
Profit before tax162145+11.6%
Net profit119128−7.0%
EPS₹3.74₹20.10−81.4%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹1,437 crNet profit₹119 crNet margin8.3%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
14,742————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
115115102157107
3,1863,186185324293
17,814————
4,5373,9612,7092,3282,255
—+46.2%+16.4%+3.2%—
596510380308337
13.1%12.9%14.0%13.2%15.0%
403363351284312
188197347267310
4.1%5.0%12.8%11.5%13.8%
₹5.92₹6.20₹10.91₹8.39₹9.76
—−43.2%+30.0%−14.0%—
—22638024691.7
—−102−66.3−28.5−45.0
12512531421846.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ZYDUSWELL₹463.60

Zydus Wellness Ltd.

· FMCG & Retail
₹ CrorePeersDABUREMAMILTDTATACONSUMLTFOODSHONASAGILLETTEEIDPARRYDOMSMcap ₹14,742 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————14,742.5
- Cash, Equiv & ST Investments107.0156.9102.4114.8114.8
+ Total Debt292.5324.0185.03,186.43,186.4
Enterprise Value————17,814.1
Revenue2,254.82,327.82,708.93,961.04,537.1
Growth %, YoY—+3.2+16.4+46.2—
EBITDA337.2308.2379.7509.7595.8
Margin %14.9513.2414.0212.8713.13
EBIT312.1284.4351.3363.0402.8
Net Income310.4266.9346.9197.2188.2
Margin %13.7611.4712.814.984.15
EPS, Adj (current shares)9.768.3910.916.205.92
Growth %, YoY—-14.0+30.0-43.2—
Cash from Operations91.7246.4380.0226.4—
Capital Expenditures-45.0-28.5-66.3-101.7—
Free Cash Flow46.8217.9313.7124.7124.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Zydus Wellness financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Zydus Wellness (NSE: ZYDUSWELL) had a market capitalisation of ₹15,248 crore at the 29 October 2026 close (₹479.50 a share), a PE ratio of 81.0 on the last four quarters' profit and a price-to-book ratio of 2.62. In FY26 its consolidated net profit was ₹197 crore on revenue of ₹3,961 crore; in Q1 FY27 (April–June 2026) it was ₹119 crore, down 7.0% year on year. Its debt-to-equity ratio was 0.55 on 31 March 2026. Promoters held 69.64% of the shares on 30 September 2026.

Share price used
₹479.50 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026
Share price and live chart
₹479.50 · 29 Oct close

Zydus Wellness at a glance · consolidated

Market cap
₹15,248 Crat ₹479.50 · 29 Oct close
PE ratio (last 4 quarters)
81.077.3 on FY26 profit
Price to book (PB)
2.62book value ₹183.21 a share
ROE (FY26)
3.4%−2.9 pts vs FY25ROCE 4.8%
Debt to equity
0.55net debt ₹3,071 Cr
Promoter holding
69.64%unchanged vs 30 Jun 202630 September 2026
Net worth
₹5,826 Cr+2.7% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹125 Cr−60.2% vs FY25
EPS (FY26)
₹6.20

Questions

What is the Zydus Wellness PE ratio today?

Zydus Wellness' PE ratio is 81.0 at the 29 October 2026 close (₹479.50 a share): a market capitalisation of ₹15,248 crore divided by consolidated net profit of ₹188 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹197 crore) it is 77.3. These four quarters include net exceptional items of −₹40.8 crore (one-off charges reported separately), so the ratio on recurring profit would differ.

What is the Zydus Wellness PB ratio (price to book value)?

Zydus Wellness' price-to-book (PB) ratio is 2.62 at the 29 October 2026 close: a market capitalisation of ₹15,248 crore divided by shareholders' equity (book value) of ₹5,826 crore on 31 March 2026. That is a book value of ₹183.21 per share against a share price of ₹479.50.

What is the Zydus Wellness ROE and ROCE?

In FY26, Zydus Wellness' return on equity (ROE) was 3.4% and its return on capital employed (ROCE) was 4.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 6.3% and ROCE 6.3%.

What is the Zydus Wellness market cap?

Zydus Wellness' market capitalisation was ₹15,248 crore at the 29 October 2026 close: 31.8 crore shares at ₹479.50 each.

Is Zydus Wellness debt free?

No. Zydus Wellness had borrowings of ₹3,186 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.55. Its cash and current investments were ₹115 crore, so its net debt was ₹3,071 crore.

What is the Zydus Wellness dividend in 2026 and its record date?

In 2026, Zydus Wellness has declared one dividend: ₹1.20 with record date 17 July 2026.

What is the Zydus Wellness debt to equity ratio?

Zydus Wellness' debt-to-equity ratio was 0.55 on 31 March 2026: borrowings of ₹3,186 crore against total equity of ₹5,826 crore. A year earlier, on 31 March 2025, it was 0.03.

What is the Zydus Wellness net worth?

Zydus Wellness' net worth — shareholders' equity in its consolidated balance sheet — was ₹5,826 crore on 31 March 2026, up 2.7% from ₹5,672 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹15,248 crore at the 29 October 2026 close.

What is the Zydus Wellness book value per share?

Zydus Wellness' book value per share was ₹183.21 on 31 March 2026: shareholders' equity of ₹5,826 crore divided by the 31.8 crore shares in issue. The share price at the 29 October 2026 close was ₹479.50.

What is the Zydus Wellness EPS?

Zydus Wellness' basic earnings per share (EPS) were ₹6.20 in FY26.

What is the Zydus Wellness promoter holding?

Promoters held 69.64% of Zydus Wellness on 30 September 2026, unchanged from the previous quarter and up 0.01 percentage points from 69.63% a year earlier, according to the shareholding pattern filed with NSE.

When are the Zydus Wellness next results?

Zydus Wellness will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Zydus Wellness shareholding pattern?

On 30 September 2026, Zydus Wellness' shares were held by promoters 69.64%, foreign portfolio investors (FII/FPI) 3.56%, domestic institutions (DII) 19.39% (including mutual funds at 18.72%) and retail and other non-institutional investors 7.41%. Over the year, FII holding was up 0.13 percentage points from 3.43% and DII holding was up 0.63 percentage points from 18.76%.

How does the Zydus Wellness PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit, Zydus Wellness' PE ratio is 77.3, the highest of the four: Dabur India 34.6, Emami 20.9 and Tata Consumer 65.5, a peer average of 40.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.

Zydus Wellness vs Dabur India: how do they compare?

In FY26, Zydus Wellness earned net profit of ₹197 crore on revenue of ₹3,961 crore, against ₹1,895 crore on ₹13,193 crore for Dabur India. Zydus Wellness' operating margin was 9.2% (Dabur India 15.0%) and its return on equity 3.4% (Dabur India 17.1%). At the 29 October 2026 close, Zydus Wellness' market capitalisation was ₹15,248 crore against ₹65,638 crore for Dabur India, and its PE ratio on FY26 profit 77.3 against 34.6.

What is the Zydus Wellness free cash flow?

In FY26, Zydus Wellness generated ₹226 crore of cash from operations and spent ₹102 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹125 crore. In FY25 it was ₹314 crore.

What are the Zydus Wellness latest quarterly results?

Zydus Wellness' latest results are for Q1 FY27 (April–June 2026), filed on 4 August 2026: consolidated net profit ₹119 crore, down 7.0% from ₹128 crore in Q1 FY26; revenue from operations ₹1,437 crore, up 66.9% year on year.

What is the Zydus Wellness revenue and profit in FY26?

In FY26 (April 2025–March 2026), Zydus Wellness' consolidated net profit was ₹197 crore, down 43.2% from ₹347 crore in FY25, on revenue from operations of ₹3,961 crore (up 46.2%). Over three years, from FY23, net profit was down 36.5%.

How does Zydus Wellness compare with its peers?

On FY26 consolidated figures, against Dabur India, Emami and Tata Consumer: Zydus Wellness' operating margin of 9.2% is the lowest of the four (Dabur India 15.0%, Emami 20.8%, Tata Consumer 10.7%; peer average 15.5%); its return on equity of 3.4% is the lowest of the four (Dabur India 17.1%, Emami 27.6%, Tata Consumer 7.4%; peer average 17.3%); its revenue growth over three years of 20.7% a year is the highest of the four (Dabur India 4.6% a year, Emami 3.5% a year, Tata Consumer 13.8% a year; peer average 7.3% a year).

Where do these Zydus Wellness figures come from?

From Zydus Wellness' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.